Sep 30, 2019
1:4
For every 4 shares held, investors received 1.
The split itself did not change the total investment value.
Relmada Therapeutics, Inc. (GETTEX:4E2) operates in the Pharmaceuticals: major industry.
Relmada Therapeutics, Inc. company overviewRelmada Therapeutics, Inc.'s most recent stock split was on September 30, 2019. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
Relmada Therapeutics, Inc. (GETTEX:4E2) has split its stock 2 times: a 1-for-5 reverse split on August 12, 2015 and a 1-for-4 reverse split on September 30, 2019.
Relmada Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between August 12, 2015 and September 30, 2019.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Relmada Therapeutics, Inc.'s 1-for-4 reverse split on September 30, 2019, every 4 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Relmada Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on September 30, 2019, 7 years ago. Companies announce splits in advance, and any new GETTEX:4E2 split will appear on this page.